| Product Information |
| Synonym(s) |
LDN-193189 hydrochloride, LDN193189 HCl |
| Chemical Name |
4-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline |
| Application |
LDN 193189 HCl is a selective BMP signaling inhibitor |
| CAS Number |
1062368-62-0 |
| Purity |
≥98.0% |
| Molecular Weight |
442.94 |
| Molecular Formula |
C₂₅H₂₂N₆ HCl |
| SMILES |
C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3.Cl |
| Target & IC50 |
ALK2: IC50 = 5 nM ALK3: IC50 = 30 nM |
| Solubility |
DMSO: 55.23mg/ml (100 mM) |
| Preparing Stock Solutions |
| ConcentrationSolventMass |
1 mg |
5 mg |
10 mg |
| 1 mM |
2.2576 ml |
11.2881 ml |
22.5763 ml |
| 5 mM |
0.4515 ml |
2.2576 ml |
4.5153 ml |
| 10 mM |
0.2258 ml |
1.1288 ml |
2.2576 ml |
| 50 mM |
0.0452 ml |
0.2258 ml |
0.4515 ml |
|
| Shipping |
Gel Pack |
| Storage |
Store at -20°C |
| Research Use |
For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |